Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) EBT Margin Growth (3y) (2015 - 2026)

Analysis

Iqvia Holdings (IQV) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -317.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 501.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -173.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -684.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -522.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -6,872.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 1,748.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -8.87 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -981,044.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -317.00
Mar 31, 2026 -201.00
Dec 31, 2025 495.00
Sep 30, 2025 -16.00
Jun 30, 2025 -122.00
Mar 31, 2025 -278.00
Dec 31, 2024 340.00
Sep 30, 2024 91.00
Jun 30, 2024 497.00
Mar 31, 2024 156.00
Dec 31, 2023 376.00
Sep 30, 2023 568.00
Jun 30, 2023 1,105.00
Mar 31, 2023 621.00
Dec 31, 2022 404.00
Sep 30, 2022 761.00
Jun 30, 2022 642.00
Mar 31, 2022 715.00
Dec 31, 2021 647.00
Sep 30, 2021 608.00